Citations

Showing 10 of 108135 citations.

Platelet-Rich Emboli in Cerebral Large Vessel Occlusion Are Associated With a Large Artery Atherosclerosis Source
Wang, Shunli , Douglas, Andrew , Kadirvel, Ramanathan , Thacker, Ike, Gounis, Matthew J. , Chueh, Ju-Yu , Puri, Ajit S , Sauvageau, Eric , Aghaebrahim, Amin, Kvamme, Peter , Kallmes, David F. , Doyle, Karen , Brinjikji, Waleed , Fitzgerald, Seán , Dai, Daying , Layton, Kennith F. , Almekhlafi, Mohammed , Demchuk, Andrew M. , Hanel, Ricardó A. , Yoo, Albert J. , Mendes Pereira, Vitor , Kayan, Yasha , Almandoz, Josser E Delgado , Nogueira, Raul G. , Rabinstein, Alejandro A.

Mayo Clinic

Stroke | May 29, 2019 | Volume: 50 | Issue: 7 | Pages: 1907-1910

10.1161/strokeaha.118.024543 | PMID 31138084 Get It

Background and Purpose— Nearly 30% of large vessel occlusion acute ischemic stroke clots are from an unknown source. We assessed histological clot composition in a series of patients with large vessel occlusion and investigated correlations between clot composition and stroke pathogenesis. Methods— As part of the multi-institutional STRIP registry (Stroke Thromboembolism Registry of Imaging and Pathology), consecutive emboli retrieved during mechanical thrombectomy were stained using Martius Scarlett Blue and analyzed using machine learning software. We assessed proportions of red blood cells, fibrin, platelets, and white blood cells. Correlations between clot components and stroke pathogenesis (large artery atherosclerosis, cardioembolism, and stroke of undetermined pathogenesis) were assessed using SPSS22. Results— One hundred five patients were included. The proportion of platelet-rich clots (55.0% versus 21.2%; P =0.005) and percentage of platelet content (22.1±4.2% versus 13.9±14.2%; P =0.03) was significantly higher in the large artery atherosclerosis group compared with the cardioembolic group. The proportion of platelet-rich clots (50.0% versus 21.2%; P =0.024) was also significantly higher in the cryptogenic group compared with cardioembolic cases. Large artery atherosclerosis and cryptogenic cases had a similar proportion of platelet-rich clots (55.0% versus 50.0%; P =0.636). There was no significant difference between stroke pathogenesis and the other major clot components. Conclusions— High platelet content of emboli is associated with a large artery atherosclerosis etiology of large vessel occlusion.
Heritability in genetic heart disease: the role of genetic background
Jansweijer, Joeri A. , Spaendonck‐Zwarts, Karin Y. van, Tanck, Michael W.T. , Tintelen, J. Peter van , Christiaans, Imke , Smagt, Jasper J. van der , Vermeer, Alexa M.C. , Bos, J. Martijn , Moss, Arthur J. , Swan, Heikki, Priori, Silvia G. , Rydberg, Annika , Tfelt‐Hansen, Jacob , Ackerman, Michael J. , Olivotto, Iacopo , Berg, Maarten P. van den , WILDE, ARTHUR A. M., Pinto, Yigal M. , van Tintelen, J Peter , Olivotto, Iacopo , Bos, Johan M , Tanck, Michael , Tfelt-Hansen, Jacob , van den Berg, Maarten P , Charron, Philippe , Gimeno, Juan Ramón , Priori, Silvia

Mayo Clinic

Open Heart | May 29, 2019 | Volume: 6 | Issue: 1 | Pages: e000929

10.1136/openhrt-2018-000929 | PMID 31245010 Get It

Background Mutations in genes encoding ion channels or sarcomeric proteins are an important cause of hereditary cardiac disease. However, the severity of the resultant disease varies considerably even among those with an identical mutation. Such clinical variation is often thought to be explained largely by differences in genetic background or ‘modifier genes’. We aimed to test the prediction that identical genetic backgrounds result in largely similar clinical expression of a cardiac disease causing mutation, by studying the clinical expression of mutations causing cardiac disease in monozygotic twins. Methods We compared first available clinical information on 46 monozygotic twin pairs and 59 control pairs that had either a hereditary cardiomyopathy or channelopathy. Results Despite limited power of this study, we found significant heritability for corrected QT interval (QTc) in long QT syndrome (LQTS). We could not detect significant heritability for structural traits, but found a significant environmental effect on thickness of the interventricular septum in hypertrophic cardiomyopathy. Conclusions Our study confirms previously found robust heritability for electrical traits like QTc in LQTS, and adds information on low or lacking heritability for structural traits in heritable cardiomyopathies. This may steer the search for genetic modifiers in heritable cardiac disease.
Effects of immediate versus gradual nicotine reduction in cigarettes on biomarkers of biological effects
Hatsukami, Dorothy K. , Luo, Xianghua , Heskin, Alisa K., Tang, Mei Kuen , Carmella, Steven G. , Jensen, Joni , Robinson, Jason D. , Vandrey, Ryan G. , Drobes, David J., Strasser, Andrew A. , Al’Absi, Mustafa , Leischow, Scott J. , Ikuemonisan, Joshua , Benowitz, Neal L. , Cinciripini, Paul M , Benowitz, Neal L , Koopmeiners, Joseph Stephen , Donny, Eric C. , Hecht, Stephen S.

Mayo Clinic

Addiction | May 29, 2019 | Volume: 114 | Issue: 10 | Pages: 1824-1833

10.1111/add.14695 | PMID 31140663 Get It

Abstract Aim A previous study showed significantly greater reductions in number of cigarettes smoked and biomarkers of toxicant and carcinogen exposure in smokers assigned to immediate reduction of nicotine in cigarettes to very low levels versus gradually over time or continued smoking of normal nicotine content cigarettes. This study examines the effects of these approaches on selected biomarkers associated with harmful biological effects. Design Three‐arm, randomized controlled trial. Setting Ten United States academic institutional sites. Participants Daily smokers uninterested in quitting smoking with a mean age of 45.1 [standard deviation (SD) = 13.4)] years and smoking 17.1 (SD = 8.5) cigarettes/day; 43.9% (549 of 1250) female; 60.6% (758 of 1250) white ethnicity. Interventions (1) Smoking cigarettes where nicotine content was immediately reduced to very low levels ( n = 503); (2) smoking cigarettes where nicotine content was gradually reduced, with dose changes occurring monthly ( n = 498); and (3) continued smoking with normal nicotine content cigarettes ( n = 249). Measurements Smokers were assessed at baseline while smoking their usual brand cigarettes, and again at 4, 8, 12, 16 and 20 weeks. Outcomes were areas under the concentration time curve (AUC) for the period of study of biomarkers of inflammation, oxidative stress and hematological parameters. Findings No consistent significant differences were observed across groups (Bayes factors showing data to be insensitive), with the only exception being red blood cell size variability, which was observed to be lower in the immediate versus gradual nicotine reduction [mean difference = −0.11; 95% confidence interval (CI) = –0.18, −0.04, P = 0.004] and normal nicotine control groups (mean difference = − 0.15, 95% CI = –0.23, −0.06, P = 0.001). Conclusion It remains unclear whether switching to very low nicotine cigarettes leads to a short‐term reduction in biomarkers of tobacco‐related harm.
Identification of Apnea Events Using a Chest-Worn Monitor Compared to Laboratory-Based Polysomnography in Patients Suspected of Obstructive Sleep Apnea
Toledo, Meynard John L. , Parish, James M., Salazar, Eduardo, Gupta, Mayank , Wang, Qiao , Turaga, Pavan K. , Buman, Matthew P.

Mayo Clinic

Journal for the Measurement of Physical Behaviour | May 29, 2019 | Volume: 2 | Issue: 2 | Pages: 103-108

10.1123/jmpb.2018-0013 Get It

Incipient Syphilitic Papillitis
Chen, John J. , Bhatti, M. Tariq , Garrity, James, Thurtell, Matthew J. , Chen, John J , Bradley, Elizabeth A.

Mayo Clinic

Neuro-Ophthalmology | May 29, 2019 | Volume: 44 | Issue: 1 | Pages: 11-15

10.1080/01658107.2019.1615959 | PMID 32076443 Get It

Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG)-Positive Optic Perineuritis
López‐Chiriboga, A. Sebastian , Stavern, Gregory Van , Pittock, Sean J. , Fryer, Jim, Bhatti, M. Tariq , Chen, John J. , Pittock, S J , Chen, John J , Flanagan, Eoin P.

Mayo Clinic

Neuro-Ophthalmology | May 29, 2019 | Volume: 44 | Issue: 1 | Pages: 1-4

10.1080/01658107.2019.1607883 | PMID 32076441 Get It

Pulmonary Complications of Rheumatoid Arthritis
Farquhar, Hamish , Vassallo, Robert , Edwards, Adrienne L. , Matteson, Eric L. , Vassallo, Robert

Mayo Clinic

Seminars in Respiratory and Critical Care Medicine | May 28, 2019 | Volume: 40 | Issue: 02 | Pages: 194-207

10.1055/s-0039-1683995 | PMID 31137060 Get It

Rheumatoid arthritis (RA) is a common chronic autoimmune disorder that characteristically causes joint inflammation and damage. In addition, many patients develop extraarticular manifestations which may cause significant comorbidity and premature mortality.Some respiratory tract involvement of the upper and lower airways and parenchymal disease features are unique to RA, including cricoarytenoid arthritis and RA pulmonary nodulosis, and others, especially the interstitial parenchymal involvement, occur in many other idiopathic and autoimmune diseases. The pathophysiology of lung disease is not well understood. Rheumatoid lung disease may even predate the onset of joint disease, and could be triggered by chronic airway and alveolar epithelial injury. Chronic systemic inflammation and risk factors such as cigarette smoking, infection, host genetics, and immune dysregulation are contributors. Treatment of the respiratory disease is directed at reducing the systemic inflammation of RA. Less well understood is the management of the interstitial lung disease of RA, for which antifibrotic and immune suppressive agents may be helpful. The management of RA-related lung disease is perhaps the major remaining hurdle in reduction of the disease burden related to extraarticular manifestations of this disease.
BCL6 modulates tissue neutrophil survival and exacerbates pulmonary inflammation following influenza virus infection
Zhu, Bibo , Zhang, Ruixuan, Li, Chaofan , Jiang, Li , Xiang, Min , Ye, Zhenqing , Kita, Hirohito , Melnick, Ari , Sun, Jie , Sun, Jie , Kita, H , Melnick, Ari , Li, Chaofan , Dent, Alexander L.

Mayo Clinic

Proceedings of the National Academy of Sciences | May 28, 2019 | Volume: 116 | Issue: 24 | Pages: 11888-11893

10.1073/pnas.1902310116 | PMID 31138703 Get It

Neutrophils are vital for antimicrobial defense; however, their role during viral infection is less clear. Furthermore, the molecular regulation of neutrophil fate and function at the viral infected sites is largely elusive. Here we report that BCL6 deficiency in myeloid cells exhibited drastically enhanced host resistance to severe influenza A virus (IAV) infection. In contrast to the notion that BCL6 functions to suppress innate inflammation, we find that myeloid BCL6 deficiency diminished lung inflammation without affecting viral loads. Using a series of Cre-transgenic, reporter, and knockout mouse lines, we demonstrate that BCL6 deficiency in neutrophils, but not in monocytes or lung macrophages, attenuated host inflammation and morbidity following IAV infection. Mechanistically, BCL6 bound to the neutrophil gene loci involved in cellular apoptosis in cells specifically at the site of infection. As such, BCL6 disruption resulted in increased expression of apoptotic genes in neutrophils in the respiratory tract, but not in the circulation or bone marrow. Consequently, BCL6 deficiency promoted tissue neutrophil apoptosis. Partial neutrophil depletion led to diminished pulmonary inflammation and decreased host morbidity. Our results reveal a previously unappreciated role of BCL6 in modulating neutrophil apoptosis at the site of infection for the regulation of host disease development following viral infection. Furthermore, our studies indicate that tissue-specific regulation of neutrophil survival modulates host inflammation and tissue immunopathology during acute respiratory viral infection.
The Importance and Challenges of Developing a Pharmacogenetics Test for Hypertension
Snyder, Eric M., Kelley, Eli F. , Sprissler, Ryan , Olson, Thomas P.

Mayo Clinic

Pharmacogenomics | May 28, 2019 | Volume: 20 | Issue: 8 | Pages: 563-566

10.2217/pgs-2019-0056 | PMID 31136254 Get It

Yersinia kristensenii subsp. rochesterensis subsp. nov., isolated from human feces
Cunningham, Scott A. , Jeraldo, Patricio , Patel, Robin , Jeraldo, Patricio R , Patel, Robin , Cunningham, Scott A

Mayo Clinic

International Journal of Systematic and Evolutionary Microbiology | May 28, 2019 | Volume: 69 | Issue: 8 | Pages: 2292-2298

10.1099/ijsem.0.003464 | PMID 31135335 Get It